Keep checking for updates and new content.

Androgen-deprivation therapy (ADT) can be associated with significant psychological effects in patients with prostate cancer. Additionally, these side effects—which include depression, Alzheimer disease, and coronary disease—are often under-reported by patients. Read the article here.

{ 0 comments }

Selenium May Cut Aggressive Prostate Cancer Risk

by Jim Barney on February 19, 2017

Men with higher selenium levels may be at lower risk of aggressive prostate cancer, according to a new study. Read the article here.

{ 0 comments }

Prostate Cancer Surgery and Pelvic Floor Exercises: What to Know

February 19, 2017

In this video, shared by Continence Foundation of Australia, listen to Specialist Continence & Women’s Health Physiotherapist, Shan Morrison, as she discusses urinary incontinence in men after prostate cancer surgery. Dr. Morrison also talks about pelvic floor exercises and how these can help men in their recovery. Watch the video here.

Read the article or watch the video →

Prostate Cancer Treatment Can Raise Dementia Risk

February 19, 2017

Reducing testosterone levels with androgen deprivation therapy, or A.D.T., is a common treatment for prostate cancer. But a new study has found that it more than doubles the risk of dementia. Read the article here.

Read the article or watch the video →

After 16 years, robotic surgery for prostate cancer still is debated

February 19, 2017

Robot-assisted and open radical surgeries for prostate cancer have similar outcomes for patients at 3 months, according to clinical trial results published in the Lancet. Read the first article here. Read the second article here.

Read the article or watch the video →

Alcohol intake, drinking patterns, and prostate cancer risk and mortality

February 19, 2017

A Finnish study found that heavy regular alcohol consumption and binge drinking during midlife were significantly associated with an increased risk of prostate cancer risk. Men who were heavy drinkers (>14 drinks/week) were at a 46% higher risk of prostate cancer compared to those who were light drinkers (≤ 3 drinks/week). Among current drinkers, binge […]

Read the article or watch the video →

Trends in targeted prostate brachytherapy: from multiparametric MRI to nanomolecular radiosensitizers

February 19, 2017

Brachytherapy, a form of localized radiation therapy, has been shown to be one of the most effective methods for delivering high radiation doses to the cancer; however, recent evidence suggests that increasing the localized radiation dose without bound may cause unacceptable increases in long-term side effects. This review focuses on methods that have been proposed, […]

Read the article or watch the video →

Prostate Multiparametric MRI Feasible for PCa Screening

February 19, 2017

Robert K. Nam, MD, from the Sunnybrook Health Sciences Center in Toronto, and colleagues examined the feasibility of prostate MRI as the primary screening test for prostate cancer in a cohort of unselected men from the general population. All participants underwent prostate multiparametric MRI and random or targeted biopsies as well as prostate-specific antigen testing. […]

Read the article or watch the video →

Metastatic prostate cancer cases skyrocket

February 19, 2017

The number of new cases of metastatic prostate cancer climbed 72 percent in the past decade from 2004 to 2013, reports a new Northwestern Medicine study. The report considers whether a recent trend of fewer men being screened may be contributing to the rise, or whether the disease has become more aggressive—or both. Read the […]

Read the article or watch the video →

Roswell Park-Led Study: Photoacoustic Imaging Is Promising Option for Noninvasive Monitoring of Prostate Cancer

February 19, 2017

A team of scientists led by researchers from Roswell Park Cancer Institute in Buffalo have demonstrated that photoacoustic imaging (PAI) may be an effective tool for more accurately viewing and monitoring prostate cancer. Photoacoustic imaging of enabled good discrimination between cells with and without the cancer marker, PSMA. Read the article here.

Read the article or watch the video →